IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy
The Journal of Haemophilia Practice · 2013
DOI: 10.17225/jhp.00020 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Haemophilia Practice, 2013. Verfasst von Melanie Bladen und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
The use of BtA in spasticity management is well documented in the literature for the management of hypertonicity in children with cerebral palsy.
Methods
We report a case of a 2-year-old boy with severe haemophilia and cerebral palsy who received intramuscular injections of botulinum toxin-A (BtA) to reduce his spastic diplegia lower limb hypertonicity.
Results
Following treatment, clinical and formal assessments demonstrated positive changes in ambulation, tolerance of orthotics, functional abilities and musculoskeletal range of movement and no adverse bleeding side effects.
Conclusion
The use of BtA should be considered for the management of hypertonicity in children with haemophilia and cerebral palsy.
Zitieren
APA
Bladen, M., Edwards, K., Khair, K., & Main, E. (2013). IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy. The Journal of Haemophilia Practice. https://doi.org/10.17225/jhp.00020
Vancouver
Bladen M, Edwards K, Khair K, Main E. IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy. The Journal of Haemophilia Practice. 2013. doi:10.17225/jhp.00020
BibTeX
@article{Bladen2013,
author = {Bladen, Melanie and Edwards, Karen and Khair, Kate and Main, Eleanor},
title = {IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy},
journal = {The Journal of Haemophilia Practice},
year = {2013},
doi = {10.17225/jhp.00020}
}
EUVIMED